2014
DOI: 10.3109/1547691x.2014.882996
|View full text |Cite
|
Sign up to set email alerts
|

Is murine gammaherpesvirus-68 (MHV-68) a suitable immunotoxicological model for examining immunomodulatory drug-associated viral recrudescence?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
8
0

Year Published

2014
2014
2023
2023

Publication Types

Select...
6
2
1

Relationship

1
8

Authors

Journals

citations
Cited by 10 publications
(8 citation statements)
references
References 157 publications
(199 reference statements)
0
8
0
Order By: Relevance
“…We have previously discussed how the MHV-68 model may be of further use for testing the effects of immunomodulatory compounds on viral recrudescence (Aligo et al, 2014). The focus of this report was to first establish assays for examination of MHV-68 infection.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…We have previously discussed how the MHV-68 model may be of further use for testing the effects of immunomodulatory compounds on viral recrudescence (Aligo et al, 2014). The focus of this report was to first establish assays for examination of MHV-68 infection.…”
Section: Discussionmentioning
confidence: 99%
“…Direct small animal models to examine these human viruses do not exist, indicating a need for better understanding of gammaherpesvirus pathogenesis. Murine gammaherpesvirus-68 (MHV-68) may be a relevant model for studying gammaherpesvirus pathogenesis as it relates to human disease (Aligo et al, 2014). However, in vivo models to examine these areas have yet to be fully characterized and an understanding of the mechanism of viral transmission in animal populations is lacking.…”
Section: Introductionmentioning
confidence: 99%
“…Using recombinant MHV-68 is also a highly suitable model to test the immunogenicity and protective capacity of HCV candidate vaccine antigens (El-Gogo et al, 2008). Very important is the use of MHV-68 as immunotoxicological model for examining immunomodulatory drug-associated viral recrudescence (Aligo et al, 2015b). MHV-68 is being evaluated as a model of EBV infection for use in investigation of the effects of immunomodulatory therapy on herpesvirus pathogen-esis in humans (Aligo et al, 2015a).…”
Section: Genome Of Mhv-68mentioning
confidence: 99%
“…While murine herpesvirus-68 (MHV-68) is a natural pathogen of rodents, the pathogenesis of MHV-68 infection in mice mimics that of EBV/KSHV infection in humans with acute lytic viral replication, followed by the dissemination and establishment of persistent latency [79].…”
Section: Murine Herpesvirus-68-encoded Lncrnasmentioning
confidence: 99%